Aref Al-Kali

Trials

Studies that name Aref Al-Kali as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:22 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT02634827 · Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation

  Mayo Clinic · terminated · Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, FLT3 Tyrosine Kinase Domain Point Mutation · principal investigator
• Ph2
  NCT02484430 · Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia

  National Cancer Institute (NCI) · completed · B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · principal investigator
• Ph1
  NCT02129101 · Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies

  Mayo Clinic · completed · Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Essential Thrombocythemia · principal investigator
• Ph2
  NCT01806571 · Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

  Mayo Clinic · completed · Untreated Adult Acute Myeloid Leukemia · principal investigator
• Ph2
  NCT01670084 · Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

  Mayo Clinic · withdrawn · B-cell Adult Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Pathology Research Shared Resource
  P30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI THOMAS J FLOTTE · fiscal years 2011 to 2026
  Named on NCT02634827, NCT02129101, NCT01806571
• NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis
  UM1CA186686 · NCI · MAYO CLINIC ROCHESTER · PI ALEX A. ADJEI · fiscal years 2014 to 2019
  Named on NCT02484430